NYSE · TPB

Turning Point Brands, Inc.

$78.65 +$2.53 (+3.32%) 1D Pre-market

Key Metrics

$1.47B
Market cap
26.59×
P/E · TTM
Revenue · TTM
$55.44M
Net income
EPS · TTM $3.04
Dividend yield 0.4%
Free cash flow $1.22M
Beta · 1Y 0.61
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 21
    From its Feb 25 high, the share price fell 51%.

    Peak close $142.98 on Feb 25; trough close $70.59 on Apr 21. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -51%
  • Apr 21
    The stock moved -16.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 21
  • Mar 2
    The stock moved -20.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 2

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.47B
Enterprise value$1.56B
Shares outstanding19.4M
52-wk range$65.80 – $146.90
Avg volume · 20D219.9K
Net cash −$86.60M
Book value / share$21.12
IndustryTobacco Products
ExchangeNYSE
About Turning Point Brands, Inc.
IPO dateMay 11, 2016
Employees484

Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E26.59
P/S
P/FCF1,205.44
EV/EBITDA
EV/Sales
Graham №$38.00

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 19.3% · 13.6%

Financial Health

Current ratio5.87
Quick ratio4.05
Debt / equity0.76
Debt / EBITDA
Net cash −$86.60M
Working capital$346.92M

Cash Flow · TTM

Operating CF $17.71M
Capex −$16.48M
Free cash flow $1.22M
Buybacks
Dividends paid $5.81M
Shareholder yield 0.4%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$38.00 vs $78.65
Trades 2.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings